Details for Patent: 7,683,037
✉ Email this page to a colleague
Summary for Patent: 7,683,037
Title: | Myocardial perfusion imaging method |
Abstract: | The present invention relates to methods for myocardial imaging by administering at least one 2-adenosine N-pyrazole, 2-adenosine C-pyrazole or a combination thereof A.sub.2A adenosine receptor agonist to a human undergoing myocardial imaging. The invention also relates to methods of producing coronary vasodilation without significant peripheral vasodilation by administering at least one 2-adenosine N-pyrazole, 2-adenosine C-pyrazole or a combination thereof adenosine A.sub.2A adenosine receptor agonist to a human. |
Inventor(s): | Belardinelli; Luiz (Menlo Park, CA) |
Assignee: | Gilead Palo Alto, Inc. (Foster City, CA) |
Application Number: | 10/629,368 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,683,037
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,683,037
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2003259264 | ⤷ Try a Trial | |||
Canada | 2492855 | ⤷ Try a Trial | |||
China | 1671399 | ⤷ Try a Trial | |||
European Patent Office | 1524984 | ⤷ Try a Trial | |||
Israel | 166555 | ⤷ Try a Trial | |||
Japan | 2005538190 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |